Audax-backed CorEvitas buys Vestrum Health

CorEvitas, which is backed by Audax Private Equity has acquired Vestrum Health, a provider of data analytics for retina electronic health record information.

CorEvitas, which is backed by Audax Private Equity has acquired Vestrum Health, a provider of data analytics for retina electronic health record information. No financial terms were disclosed.

PRESS RELEASE

Audax Private Equity Portfolio Company, CorEvitas, acquires Vestrum Health

The Company
Vestrum Health is a leader in data analytics for retina electronic health record (“EHR”) information, empowering retina practices to optimize clinical performance and patient outcomes by leveraging real-world clinical applications. Vestrum Health’s data provides insightful views across the drug life cycle to biopharmaceutical companies focused on retinal diseases.

The Deal
CorEvitas, LLC (“CorEvitas”), a portfolio company of Audax Private Equity (“Audax”), has completed the acquisition of Vestrum Health, representing the company’s second acquisition since Audax’ investment.

The Thesis
In December of 2019, Audax acquired CorEvitas. Based in Waltham, MA, CorEvitas is a built-for-purpose source of gold-standard real-world evidence that leverages its proprietary data to help biopharmaceutical customers uncover clinical insights that lead to safer, more effective treatments and better patient care. In July of 2021, CorEvitas acquired Vestrum Health, diversifying CorEvitas’ data collection and analytics capabilities, therapeutic areas, and global network of physician partnerships. The combined platform will provide pharmaceutical companies with expanded reach to targeted populations, additional sources of data, and curated analytics platforms to help ensure the safety and efficacy of their drugs.